vancomycin hcl Search Results


vancomycin hydrochloride  (TargetMol)
94
TargetMol vancomycin hydrochloride
Vancomycin Hydrochloride, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/Vancomycin+hydrochloride/pm37852131-82-39-45
Average 94 stars, based on 1 article reviews
vancomycin hydrochloride - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
vancomycin hcl  (Tocris)
92
Tocris vancomycin hcl
Microscopic characterization of nanofibrous mat SEM images of formulations of <t>vancomycin</t> nanofibers at magnifications of 5000x and corresponding size distribution histograms. (A) Formulation with chitosan in HFIP. (B) Formulation with chitosan and PVA in acetic acid solution (F2). (C) Formulation with chitosan and PEO in acetic acid solution (F4). Chitosan alone proved to be extremely difficult to spin due to its limited solubility (A), and for this reason, the addition of a copolymer such as PVA and PEO was explored to enhance the electrospinnability properties of chitosan (B,C).
Vancomycin Hcl, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/Vancomycin+HCl/pmc10938330-24-0-5
Average 92 stars, based on 1 article reviews
vancomycin hcl - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
vancomycin  (Selleck Chemicals)
93
Selleck Chemicals vancomycin
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/Vancomycin+HCl/pmc09096618-60-27-28
Average 93 stars, based on 1 article reviews
vancomycin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
vancomycin  (Chem Impex International)
95
Chem Impex International vancomycin
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/Vancomycin+hydrochloride/10__1038_slash_nm__3145__-622-28-29
Average 95 stars, based on 1 article reviews
vancomycin - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
vancomycin hcl  (AG Scientific)
90
AG Scientific vancomycin hcl
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin Hcl, supplied by AG Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+hcl/pmc05751207-298-36-39
Average 90 stars, based on 1 article reviews
vancomycin hcl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
oral vancomycin vancocin hcl 125-mg capsules  (ViroPharma inc)
90
ViroPharma inc oral vancomycin vancocin hcl 125-mg capsules
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Oral Vancomycin Vancocin Hcl 125 Mg Capsules, supplied by ViroPharma inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin++vancocin+hcl++125+mg+capsules/10__1128_slash_aac__00913___12-64-10-17
Average 90 stars, based on 1 article reviews
oral vancomycin vancocin hcl 125-mg capsules - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vancomycin hydrochloride (vanc hcl, lot no. 14411001)  (Savara Pharmaceuticals)
90
Savara Pharmaceuticals vancomycin hydrochloride (vanc hcl, lot no. 14411001)
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin Hydrochloride (Vanc Hcl, Lot No. 14411001), supplied by Savara Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+hydrochloride++vanc+hcl++lot+no++14411001+/pmc04943339-50-0-11
Average 90 stars, based on 1 article reviews
vancomycin hydrochloride (vanc hcl, lot no. 14411001) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vancomycin hcl  (Chemwerth Inc)
90
Chemwerth Inc vancomycin hcl
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin Hcl, supplied by Chemwerth Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+hcl/pmc08373216__aac__00316___21___s0001-58-0-5
Average 90 stars, based on 1 article reviews
vancomycin hcl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vancomycin.hcl  (Noridem Enterprises Ltd)
90
Noridem Enterprises Ltd vancomycin.hcl
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin.Hcl, supplied by Noridem Enterprises Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+hcl/pmc07345083-126-0-4
Average 90 stars, based on 1 article reviews
vancomycin.hcl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vancomycin multicell–vancomycin hcl  (MultiCell Technologies)
90
MultiCell Technologies vancomycin multicell–vancomycin hcl
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin Multicell–Vancomycin Hcl, supplied by MultiCell Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+multicell+vancomycin+hcl/pm37890415-54-4-7
Average 90 stars, based on 1 article reviews
vancomycin multicell–vancomycin hcl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vancomycin.hcl  (Chemie GmbH)
90
Chemie GmbH vancomycin.hcl
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin.Hcl, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+hcl/pmc07345083-131-0-14
Average 90 stars, based on 1 article reviews
vancomycin.hcl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vancomycin hcl  (TOKU-E)
90
TOKU-E vancomycin hcl
Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of <t>vancomycin.</t> (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.
Vancomycin Hcl, supplied by TOKU-E, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vancomycin+hcl/vancomycin+hcl/10__1128_slash_aac__00122___17-127-0-13
Average 90 stars, based on 1 article reviews
vancomycin hcl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Microscopic characterization of nanofibrous mat SEM images of formulations of vancomycin nanofibers at magnifications of 5000x and corresponding size distribution histograms. (A) Formulation with chitosan in HFIP. (B) Formulation with chitosan and PVA in acetic acid solution (F2). (C) Formulation with chitosan and PEO in acetic acid solution (F4). Chitosan alone proved to be extremely difficult to spin due to its limited solubility (A), and for this reason, the addition of a copolymer such as PVA and PEO was explored to enhance the electrospinnability properties of chitosan (B,C).

Journal: ACS Omega

Article Title: Electrospun Chitosan-Based Nanofibrous Coating for the Local and Sustained Release of Vancomycin

doi: 10.1021/acsomega.3c08113

Figure Lengend Snippet: Microscopic characterization of nanofibrous mat SEM images of formulations of vancomycin nanofibers at magnifications of 5000x and corresponding size distribution histograms. (A) Formulation with chitosan in HFIP. (B) Formulation with chitosan and PVA in acetic acid solution (F2). (C) Formulation with chitosan and PEO in acetic acid solution (F4). Chitosan alone proved to be extremely difficult to spin due to its limited solubility (A), and for this reason, the addition of a copolymer such as PVA and PEO was explored to enhance the electrospinnability properties of chitosan (B,C).

Article Snippet: Vancomycin HCl was purchased from Tocris Bioscience (Minneapolis).

Techniques: Formulation, Solubility

Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of vancomycin. (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.

Journal: Frontiers in Microbiology

Article Title: Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L

doi: 10.3389/fmicb.2022.884034

Figure Lengend Snippet: Teicoplanin specifically inhibited the entry of pseudotyped SARS-CoV-2. (A) Schematic of the pseudotyped virus entry upon drug treatment assay. To package different pseudotyped viruses, psPAX2 plasmids, and pHIV-Luciferase plasmids were co-transfected into HEK293T cells with pcDNA3.1-SARS-CoV S, pcDNA3.1-SARS-CoV-2 S, and pCMV-VSV-G plasmids, respectively. HEK293T-hACE2 high cells were incubated with drugs and different pseudotyped viruses. The amounts of luciferase within cells were measured 48 h post infection. (B) Chemical structure of teicoplanin. (C) HEK293T-hACE2 high cells were treated with 0, 25, and 50 μM teicoplanin, respectively, followed by infecting with different pseudotyped viruses including SARS-CoV S/HIV-1, SARS-CoV-2 S/HIV-1, and VSV-G/HIV-1. The intracellular luciferase activity was measured 48 h post infection ( n = 3). (D) Chemical structure of dalbavancin. (E) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with dalbavancin ( n = 3). (F) Chemical structure of vancomycin. (G) HEK293T-hACE2 high cells were treated as in (C) , except that the drug was replaced with vancomycin ( n = 3). Data in (C,E,G) represented as mean ± SEM in triplicate. P -values were calculated by two-way ANOVA with Dunnett’s multiple comparisons test which compared the mean of each group with the mean of the control group. ns p ≥ 0.05, *** p < 0.001.

Article Snippet: For virus infection in drug treatment experiment, HEK293T-hACE2 high cells were incubated with serially diluted drugs including teicoplanin (Selleck, S1399, United States), dalbavancin (Selleck, S4848, United States), vancomycin (Selleck, S2575, United States), and camostat (Selleck, S2874, United States), and different pseudotyped viruses.

Techniques: Virus, Luciferase, Transfection, Incubation, Infection, Activity Assay, Control